A China-based biotechnology company founded in 2021, focused on building drug-delivery platforms and developing antibody-drug conjugates (ADCs), including discovery, screening, and industrialization of next-generation ADCs
A China-based biotechnology company founded in 2021, focused on building drug-delivery platforms and developing antibody-drug conjugates (ADCs), including discovery, screening, and industrialization of next-generation ADCs.